Back

Atrial extrasystoles unmask early electropathology in pediatric congenital heart disease

28 August 2022 (12:15 - 13:00)
Organised by:
Congress Presentation Part of: Lifetime and cardiac remodeling Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Nawin Ramdat Misier

Erasmus University Rotterdam, Rotterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Long-term impact of persistent vegetations at 6 month followup after treatment of infective endocarditis: a substudy of the Partial Oral vs Intravenous Antibiotic Treatment of Endocarditis (POET) tria
Ms J. Hjulmand (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Safety of heart radiotherapy for malignant cardiac tumors: a short and long term study
Doctor C. Lestuzzi (Aviano, IT)
Abstract Slides
Presentation thumbnail
Cardiac remodelling in adolescent athletes - sex differences progress through adolescence
Doctor M. Forsaa (Oslo, NO)
Abstract Slides
Presentation thumbnail
Prognostic value of left ventricular hemodynamic forces in patients with left ventricular noncompaction
Doctor A. Romero Valero (Elche, ES)
Abstract Slides
Presentation thumbnail
Maternal pre-existing diabetes and gestational diabetes and the prevalence of septal defects in the offspring
Doctor M. Hansson (Herlev, DK)
Abstract Slides

Access the full session

Session thumbnail
Lifetime and cardiac remodeling

The Event

Event poster

ESC Congress 2022

28 August 2022 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Conduction disorders in patients with congenital heart disease and right atrial volume overload: an intraoperative epicardial mapping study
31 August 2019
thumbnail
Congress Presentation
Premature ventricular beats: implications when screening adolescents
4 April 2025
thumbnail
Congress Session
Ablation and device therapy in the pediatric population
5 April 2022
thumbnail
Congress Presentation
Exploring arrhythmias in children, adolescents and young adults with cancer: the Rebuc study perspective.
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources